FDA recall D-0575-2022
Dr. Reddy's Laboratories, Inc. · Class III · drug
Product
Azacitidine, 1,00mg/Vial, One Single-dose Vial, Rx Only, Mfd. By: Dr. Reddy's Laboratories Limited, Visakhapatnam - 530 046, India, NDC 43598-305-62
Reason for recall
Failed stability specifications
Distribution
USA Nationwide
Key facts
- Status
- Terminated
- Initiation date
- 2022-01-19
- Report date
- 2022-03-02
- Termination date
- 2022-12-13
- Voluntary/Mandated
- Voluntary: Firm initiated
- Location
- Princeton, NJ, United States
Primary source
https://www.accessdata.fda.gov/scripts/ires/index.cfm?Product=D-0575-2022